UK Markets closed

NVO Jan 2024 70.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
42.00+5.80 (+16.02%)
As of 08:30AM EST. Market open.
Full screen
Previous close36.20
Open42.00
Bid41.30
Ask46.00
Strike70.00
Expiry date2024-01-19
Day's range42.00 - 42.00
Contract rangeN/A
Volume1
Open interest69
  • Globe Newswire

    Trading in Novo Nordisk shares by board members, executives and associated persons

    Bagsværd, Denmark, 2 February 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their

  • Zacks

    Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints

    Merck (MRK) beats Q4 estimates for earnings and sales. Its 2023 profit guidance disappoints. Stock declines in pre-market.

  • Motley Fool

    Novo Nordisk A/s (NVO) Q4 2022 Earnings Call Transcript

    My name is Lars Fruergaard Jorgensen, and I'm the CEO of Novo Nordisk. With me today, I have executive vice president and head of commercial strategy and corporate affairs, Camilla Sylvest; executive vice president and head of North America operations, Doug Langa; executive vice president and head of development, Martin Holst Lange; and finally, chief financial officer, Karsten Munk Knudsen.